A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
AbbVie
AbbVie
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
GlaxoSmithKline
Case Comprehensive Cancer Center